AlzeCure Pharma
1,215
SEK
-3,95 %
ALZCUR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 investor følger denne virksomhed
-3,95%
+15,71%
-39,1%
-35,2%
-58,57%
-59,61%
-76,05%
-67,72%
-87,81%
AlzeCure Pharma is a pharmaceutical company. The company focuses on research and development of drugs used for various brain diseases, with the greatest focus on Alzheimer's disease, but also on pain. The technology and research is based on its own pharmaceutical platform, where the company develops various symptom-relieving and disease-modifying drug candidates. The head office is in Huddinge.
Læs mereMarkedsværdi
107,28 mio. SEK
Aktieomsætning
21,59 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
27.2
2025
Årsrapport '24
5.5
2025
Delårsrapport Q1'25
14.5
2025
Generalforsamling '24
ViserAlle indholdstyper
AlzeCure Pharma to present at Redeye Life Science Day on December 3
AlzeCure Pharma to present at Stora Aktiedagarna in Stockholm
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools